HIF1A and idiopathic pulmonary fibrosis: After distinct treatments, the concentrations of HIF-1α and PDGF in each treatment group were significantly lower than those in the model group (P < 0.01), indicating Wuweizi, dexamethasone, and the combined therapy can remedy IPF through inhibiting vascular overgrowth.